Catherine Avery Investment Management LLC Amgen Inc Transaction History
Catherine Avery Investment Management LLC
- $167 Billion
- Q4 2025
A detailed history of Catherine Avery Investment Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Catherine Avery Investment Management LLC holds 12,539 shares of AMGN stock, worth $4.28 Million. This represents 2.46% of its overall portfolio holdings.
Number of Shares
12,539
Previous 13,600
7.8%
Holding current value
$4.28 Million
Previous $3.84 Billion
6.94%
% of portfolio
2.46%
Previous 2.47%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,319Shares Held
428MCall Options Held
6.11MPut Options Held
5.85M-
Vanguard Group Inc Valley Forge, PA53.9MShares$18.4 Billion0.24% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$10 Billion0.3% of portfolio
-
Capital International Investors Los Angeles, CA19.2MShares$6.56 Billion0.92% of portfolio
-
Capital World Investors Los Angeles, CA18.8MShares$6.42 Billion0.76% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $183B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...